Intelligent Medicine Acquisition Corp.

Intelligent Medicine Acquisition Corp. (Nasdaq: IQMD) is a blank-check company formed to pursue a business combination in the healthcare and life sciences sector, with a stated focus on technology-enabled and data-driven medicine. The SPAC completed its initial public offering in 2022 and, as reflected by its Form 10-K filed with the SEC on April 17, 2023, was continuing to operate as a pre-combination entity actively evaluating acquisition targets. The company's sponsor, Intelligent Medicine Holdings LLC, structured the vehicle to concentrate on healthcare innovation, including digital health and precision medicine opportunities. Investors seeking comprehensive deal timelines, sponsor economics, and target pipeline data for IQMD can access the full profile by signing up at SpacDesk.